TMO rated Buy with $575 target (+22%). Forward P/E 17.5x cheapest since March 2020. $6.3B FCF, Life Sciences recovery, RSI deeply oversold at 28.
Related To: Options Trading
I’m building a growing library of in-depth stock analysis reports — each one covering fundamentals, technicals, SEC filings, sentiment, and more. Launching today with six reports and many more on the way.
BE is a HOLD at $154.51. AI data center power thesis is real, but 21x P/S and lopsided insider selling mean risk/reward is unfavorable.
BROS rated Buy with $68 target (+44% upside). 28% revenue growth, transaction-driven comps, and a 4,000+ store runway offset insider selling headwinds.
GTLB rated Hold with $32 target (+41% upside). Extraordinary fundamental value offset by devastating technicals and relentless insider selling.
SNDK rated Hold with $550 target (-17%). NAND supercycle leader with 50.9% gross margins, priced for perfection. Wait for $400-450 entry.
STX rated Buy with $475 target (+24% upside). HAMR technology moat and AI storage demand drive the thesis, offset by balance sheet leverage.
TOST rated Buy with $38 target (+38% upside). PEG of 0.66, fortress balance sheet, and dominant restaurant platform drive the thesis.
Learn how to sell cash secured puts for consistent income with this step-by-step guide covering stock selection, strike prices, and risk management.
Find your next wheel strategy trade in seconds with our free options screener. Filter by DTE, premium, delta, and more.
